He appears to have deleted this tweet. It is personal now. I can only guess he is upset with Martin Rowley for not accepting an offer for SDV that he would have financially benefited from . So perhaps the board have rejected an offer from ganfeng
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status